Target Temperature Management After Cardiac Arrest
TTM
1 other identifier
interventional
950
10 countries
33
Brief Summary
Experimental studies and previous clinical trials suggest an improvement in mortality and neurological function with hypothermia after cardiac arrest. However, the accrued evidence is inconclusive and associated with risks of systematic error, design error and random error. Elevated body temperature after cardiac arrest is associated with a worse outcome. Previous trials did not treat elevated body temperature in the control groups. The optimal target temperature for post-resuscitation care is not known. The primary purpose with the TTM-trial is to evaluate if there are differences in all-cause mortality, neurological function and adverse events between a target temperature management at 33°C and 36°C for 24 hours following return of spontaneous circulation after cardiac arrest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2010
Typical duration for not_applicable
33 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 25, 2009
CompletedFirst Posted
Study publicly available on registry
November 26, 2009
CompletedStudy Start
First participant enrolled
November 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedJuly 10, 2013
July 1, 2013
2.7 years
November 25, 2009
July 8, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All-cause mortality
Maximum follow-up with a minimum of 180 days
Secondary Outcomes (12)
Composite outcome of all-cause mortality and poor neurological function (CPC 3 and 4) and composite outcome of all-cause mortality and poor neurological function (modified Rankin Scale 4 and 5)
180 days
Bleeding
During day 1-7 of intensive care treatment
Neurological function
180 days
Pneumonia
During day 1-7 of intensive care treatment
Electrolyte disorders
During day 1-7 of intensive care treatment
- +7 more secondary outcomes
Other Outcomes (3)
Quality of life
180 days
Neurological function including "Complete neurological recovery"*
180 days
Neurological function at hospital discharge and best neurological function during follow up period
Hospital discharge and 1-180 days
Study Arms (2)
Target Temperature 33°C
EXPERIMENTALTarget Temperature 36°C
ACTIVE COMPARATORInterventions
In hospital target temperature management to achieve a core body temperature of 36°C for 24 hours
In hospital target temperature management to achieve a core body temperature of 33°C for 24 hours
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years old
- Out-of-hospital cardiac arrest (OHCA) of presumed cardiac cause
- Return of spontaneous circulation (ROSC)
- Unconsciousness (Glasgow Coma Score \< 8) (patients not able to obey verbal commands)after sustained ROSC
You may not qualify if:
- In-hospital cardiac arrest
- OHCA of presumed non-cardiac cause, e.g. after trauma or dissection/rupture of major artery OR Cardiac arrest caused by initial hypoxia (i.e. drowning, suffocation, hanging).
- Known bleeding diathesis (medically induced coagulopathy (e.g warfarin, clopidogrel) does not exclude the patient).
- Suspected or confirmed acute intracranial bleeding
- Suspected or confirmed acute stroke
- Unwitnessed asystole
- Known limitations in therapy and Do Not Resuscitate-order
- Known disease making 180 days survival unlikely
- Known pre-arrest CPC 3 or 4
- Temperature \< 30°C on admission
- \> 4 hours (240 minutes) from ROSC to screening
- Systolic blood pressure \< 80 mm Hg in spite of fluid loading/vasopressor and/or inotropic medication/intra aortic balloon pump#
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Niklas Nielsenlead
- Scandinavian Critical Care Trials Groupcollaborator
- Copenhagen Trial Unit, Center for Clinical Intervention Researchcollaborator
- Lund Universitycollaborator
- The George Institute for Global Health, Australiacollaborator
Study Sites (33)
Liverpool Hospital
Sydney, Australia
North Shore Hospital
Sydney, Australia
St George Hospital
Sydney, Australia
General University Hospital
Prague, Czechia
Copenhagen University Hospital, Rigshospitalet
Copenhagen, DK2100, Denmark
San Martino Hospital
Genova, Italy
Santa Maria degli Angeli Hospital
Pordenone, Italy
Ospedale Universitario di Cattinaria
Trieste, Italy
Centre Hospitalier de Luxembourg
Luxembourg, Luxembourg
Academisch Medisch Centrum, AMC
Amsterdam, Netherlands
Onze Lieve Vrouwe Gasthuis
Amsterdam, Netherlands
Rijnstate Hospital
Arnhem, Netherlands
Leeuwarden Hospital
Leeuwarden, Netherlands
Haukeland University Hospital
Bergen, Norway
Oslo University Hospital, Rikshospitalet
Oslo, Norway
Sahlgrenska University Hospital, Östra
Gothenburg, Sweden
Sahlgrenska University Hospital
Gothenburg, Sweden
Helsingborgs Hospital
Helsingborg, 251 87, Sweden
Karlstad Central Hospital
Karlstad, Sweden
Kungälv Hospital
Kungälv, Sweden
Linköping University Hospital
Linköping, Sweden
Skåne University Hospital
Lund, Sweden
Skåne University Hospital
Malmo, Sweden
Vrinnevi Hospital
Norrköping, Sweden
Örebro University Hospital
Örebro, Sweden
Norra Älvsborgs Läns Sjukhus
Trollhättan/Vänersborg, Sweden
University Hospital of Geneva
Geneva, Switzerland
Kantonspital St Gallen
Sankt Gallen, Switzerland
Royal Bournemouth Hospital
Bournemouth, United Kingdom
University Hospital of Wales
Cardiff, United Kingdom
Guy's and St Thomas NHS Trust
London, United Kingdom
St Georges' Hospital
London, United Kingdom
Royal Berkshire NHS Foundation Trust
Reading, United Kingdom
Related Publications (34)
Nielsen N, Friberg H, Gluud C, Herlitz J, Wetterslev J. Hypothermia after cardiac arrest should be further evaluated--a systematic review of randomised trials with meta-analysis and trial sequential analysis. Int J Cardiol. 2011 Sep 15;151(3):333-41. doi: 10.1016/j.ijcard.2010.06.008. Epub 2010 Jul 1.
PMID: 20591514BACKGROUNDNielsen N, Hovdenes J, Nilsson F, Rubertsson S, Stammet P, Sunde K, Valsson F, Wanscher M, Friberg H; Hypothermia Network. Outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest. Acta Anaesthesiol Scand. 2009 Aug;53(7):926-34. doi: 10.1111/j.1399-6576.2009.02021.x. Epub 2009 Jun 22.
PMID: 19549271BACKGROUNDHolgersson J, Meyer MAS, Dankiewicz J, Lilja G, Ullen S, Hassager C, Cronberg T, Wise MP, Belohlavek J, Hovdenes J, Pelosi P, Erlinge D, Schrag C, Smid O, Brunetti I, Rylander C, Young PJ, Saxena M, Aneman A, Cariou A, Callaway C, Eastwood GM, Haenggi M, Joannidis M, Keeble TR, Kirkegaard H, Leithner C, Levin H, Nichol AD, Morgan MPG, Nordberg P, Oddo M, Storm C, Taccone FS, Thomas M, Bro-Jeppesen J, Horn J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher MJ, Friberg H, Nielsen N, Jakobsen JC. Hypothermic versus Normothermic Temperature Control after Cardiac Arrest. NEJM Evid. 2022 Nov;1(11):EVIDoa2200137. doi: 10.1056/EVIDoa2200137. Epub 2022 Jun 15.
PMID: 38319850DERIVEDBeske RP, Obling LER, Bro-Jeppesen J, Nielsen N, Meyer MAS, Kjaergaard J, Johansson PI, Hassager C. The Effect of Targeted Temperature Management on the Metabolome Following Out-of-Hospital Cardiac Arrest. Ther Hypothermia Temp Manag. 2023 Dec;13(4):208-215. doi: 10.1089/ther.2022.0065. Epub 2023 May 23.
PMID: 37219970DERIVEDArrich J, Schutz N, Oppenauer J, Vendt J, Holzer M, Havel C, Herkner H. Hypothermia for neuroprotection in adults after cardiac arrest. Cochrane Database Syst Rev. 2023 May 22;5(5):CD004128. doi: 10.1002/14651858.CD004128.pub5.
PMID: 37217440DERIVEDGrindegard L, Cronberg T, Backman S, Blennow K, Dankiewicz J, Friberg H, Hassager C, Horn J, Kjaer TW, Kjaergaard J, Kuiper M, Mattsson-Carlgren N, Nielsen N, van Rootselaar AF, Rossetti AO, Stammet P, Ullen S, Zetterberg H, Westhall E, Moseby-Knappe M. Association Between EEG Patterns and Serum Neurofilament Light After Cardiac Arrest: A Post Hoc Analysis of the TTM Trial. Neurology. 2022 Jun 14;98(24):e2487-e2498. doi: 10.1212/WNL.0000000000200335. Epub 2022 Apr 25.
PMID: 35470143DERIVEDGrand J, Kjaergaard J, Hassager C, Moller JE, Bro-Jeppesen J. Comparing Doppler Echocardiography and Thermodilution for Cardiac Output Measurements in a Contemporary Cohort of Comatose Cardiac Arrest Patients Undergoing Targeted Temperature Management. Ther Hypothermia Temp Manag. 2022 Sep;12(3):159-167. doi: 10.1089/ther.2021.0008. Epub 2021 Aug 20.
PMID: 34415801DERIVEDThomsen JH, Hassager C, Erlinge D, Nielsen N, Lindholm MG, Bro-Jeppesen J, Grand J, Pehrson S, Graff C, Kober LV, Kjaergaard J. Repolarization and ventricular arrhythmia during targeted temperature management post cardiac arrest. Resuscitation. 2021 Sep;166:74-82. doi: 10.1016/j.resuscitation.2021.07.004. Epub 2021 Jul 14.
PMID: 34271131DERIVEDDuring J, Annborn M, Cronberg T, Dankiewicz J, Devaux Y, Hassager C, Horn J, Kjaergaard J, Kuiper M, Nikoukhah HR, Stammet P, Unden J, Wanscher MJ, Wise M, Friberg H, Nielsen N. Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trial. Crit Care. 2020 Apr 28;24(1):185. doi: 10.1186/s13054-020-02904-8.
PMID: 32345356DERIVEDRundgren M, Ullen S, Morgan MPG, Glover G, Cranshaw J, Al-Subaie N, Walden A, Joannidis M, Ostermann M, Dankiewicz J, Nielsen N, Wise MP. Renal function after out-of-hospital cardiac arrest; the influence of temperature management and coronary angiography, a post hoc study of the target temperature management trial. Crit Care. 2019 May 8;23(1):163. doi: 10.1186/s13054-019-2390-0.
PMID: 31068215DERIVEDStammet P, Dankiewicz J, Nielsen N, Fays F, Collignon O, Hassager C, Wanscher M, Unden J, Wetterslev J, Pellis T, Aneman A, Hovdenes J, Wise MP, Gilson G, Erlinge D, Horn J, Cronberg T, Kuiper M, Kjaergaard J, Gasche Y, Devaux Y, Friberg H; Target Temperature Management after Out-of-Hospital Cardiac Arrest (TTM) trial investigators. Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 degrees C and 36 degrees C. Crit Care. 2017 Jun 20;21(1):153. doi: 10.1186/s13054-017-1729-7.
PMID: 28629472DERIVEDWiberg S, Hassager C, Stammet P, Winther-Jensen M, Thomsen JH, Erlinge D, Wanscher M, Nielsen N, Pellis T, Aneman A, Friberg H, Hovdenes J, Horn J, Wetterslev J, Bro-Jeppesen J, Wise MP, Kuiper M, Cronberg T, Gasche Y, Devaux Y, Kjaergaard J. Single versus Serial Measurements of Neuron-Specific Enolase and Prediction of Poor Neurological Outcome in Persistently Unconscious Patients after Out-Of-Hospital Cardiac Arrest - A TTM-Trial Substudy. PLoS One. 2017 Jan 18;12(1):e0168894. doi: 10.1371/journal.pone.0168894. eCollection 2017.
PMID: 28099439DERIVEDGlover GW, Thomas RM, Vamvakas G, Al-Subaie N, Cranshaw J, Walden A, Wise MP, Ostermann M, Thomas-Jones E, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wetterslev J, Friberg H, Nielsen N. Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest - an analysis of the TTM trial data. Crit Care. 2016 Nov 26;20(1):381. doi: 10.1186/s13054-016-1552-6.
PMID: 27887653DERIVEDGilje P, Koul S, Thomsen JH, Devaux Y, Friberg H, Kuiper M, Horn J, Nielsen N, Pellis T, Stammet P, Wise MP, Kjaergaard J, Hassager C, Erlinge D; TTM study group. High-sensitivity troponin-T as a prognostic marker after out-of-hospital cardiac arrest - A targeted temperature management (TTM) trial substudy. Resuscitation. 2016 Oct;107:156-61. doi: 10.1016/j.resuscitation.2016.06.024.
PMID: 27667713DERIVEDBro-Jeppesen J, Johansson PI, Hassager C, Wanscher M, Ostrowski SR, Bjerre M, Kjaergaard J. Endothelial activation/injury and associations with severity of post-cardiac arrest syndrome and mortality after out-of-hospital cardiac arrest. Resuscitation. 2016 Oct;107:71-9. doi: 10.1016/j.resuscitation.2016.08.006. Epub 2016 Aug 11.
PMID: 27523954DERIVEDDevaux Y, Dankiewicz J, Salgado-Somoza A, Stammet P, Collignon O, Gilje P, Gidlof O, Zhang L, Vausort M, Hassager C, Wise MP, Kuiper M, Friberg H, Cronberg T, Erlinge D, Nielsen N; for Target Temperature Management After Cardiac Arrest Trial Investigators. Association of Circulating MicroRNA-124-3p Levels With Outcomes After Out-of-Hospital Cardiac Arrest: A Substudy of a Randomized Clinical Trial. JAMA Cardiol. 2016 Jun 1;1(3):305-13. doi: 10.1001/jamacardio.2016.0480.
PMID: 27438111DERIVEDBro-Jeppesen J, Kjaergaard J, Stammet P, Wise MP, Hovdenes J, Aneman A, Horn J, Devaux Y, Erlinge D, Gasche Y, Wanscher M, Cronberg T, Friberg H, Wetterslev J, Pellis T, Kuiper M, Nielsen N, Hassager C; TTM-Trial Investigators. Predictive value of interleukin-6 in post-cardiac arrest patients treated with targeted temperature management at 33 degrees C or 36 degrees C. Resuscitation. 2016 Jan;98:1-8. doi: 10.1016/j.resuscitation.2015.10.009. Epub 2015 Oct 23.
PMID: 26525271DERIVEDLilja G, Nilsson G, Nielsen N, Friberg H, Hassager C, Koopmans M, Kuiper M, Martini A, Mellinghoff J, Pelosi P, Wanscher M, Wise MP, Ostman I, Cronberg T. Anxiety and depression among out-of-hospital cardiac arrest survivors. Resuscitation. 2015 Dec;97:68-75. doi: 10.1016/j.resuscitation.2015.09.389. Epub 2015 Oct 9.
PMID: 26433116DERIVEDStammet P, Collignon O, Hassager C, Wise MP, Hovdenes J, Aneman A, Horn J, Devaux Y, Erlinge D, Kjaergaard J, Gasche Y, Wanscher M, Cronberg T, Friberg H, Wetterslev J, Pellis T, Kuiper M, Gilson G, Nielsen N; TTM-Trial Investigators. Neuron-Specific Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33 degrees C and 36 degrees C. J Am Coll Cardiol. 2015 May 19;65(19):2104-14. doi: 10.1016/j.jacc.2015.03.538.
PMID: 25975474DERIVEDDevaux Y, Stammet P, Friberg H, Hassager C, Kuiper MA, Wise MP, Nielsen N; Biomarker subcommittee of TTM trial (Target Temperature Management After Cardiac Arrest, NCT01020916). MicroRNAs: new biomarkers and therapeutic targets after cardiac arrest? Crit Care. 2015 Feb 11;19(1):54. doi: 10.1186/s13054-015-0767-2.
PMID: 25886727DERIVEDCronberg T, Lilja G, Horn J, Kjaergaard J, Wise MP, Pellis T, Hovdenes J, Gasche Y, Aneman A, Stammet P, Erlinge D, Friberg H, Hassager C, Kuiper M, Wanscher M, Bosch F, Cranshaw J, Kleger GR, Persson S, Unden J, Walden A, Winkel P, Wetterslev J, Nielsen N; TTM Trial Investigators. Neurologic Function and Health-Related Quality of Life in Patients Following Targeted Temperature Management at 33 degrees C vs 36 degrees C After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA Neurol. 2015 Jun;72(6):634-41. doi: 10.1001/jamaneurol.2015.0169.
PMID: 25844993DERIVEDJohansson PI, Bro-Jeppesen J, Kjaergaard J, Wanscher M, Hassager C, Ostrowski SR. Sympathoadrenal activation and endothelial damage are inter correlated and predict increased mortality in patients resuscitated after out-of-hospital cardiac arrest. a post Hoc sub-study of patients from the TTM-trial. PLoS One. 2015 Mar 19;10(3):e0120914. doi: 10.1371/journal.pone.0120914. eCollection 2015.
PMID: 25789868DERIVEDBro-Jeppesen J, Kjaergaard J, Wanscher M, Nielsen N, Friberg H, Bjerre M, Hassager C. Systemic Inflammatory Response and Potential Prognostic Implications After Out-of-Hospital Cardiac Arrest: A Substudy of the Target Temperature Management Trial. Crit Care Med. 2015 Jun;43(6):1223-32. doi: 10.1097/CCM.0000000000000937.
PMID: 25756419DERIVEDBro-Jeppesen J, Annborn M, Hassager C, Wise MP, Pelosi P, Nielsen N, Erlinge D, Wanscher M, Friberg H, Kjaergaard J; TTM Investigators. Hemodynamics and vasopressor support during targeted temperature management at 33 degrees C Versus 36 degrees C after out-of-hospital cardiac arrest: a post hoc study of the target temperature management trial*. Crit Care Med. 2015 Feb;43(2):318-27. doi: 10.1097/CCM.0000000000000691.
PMID: 25365723DERIVEDBro-Jeppesen J, Hassager C, Wanscher M, Ostergaard M, Nielsen N, Erlinge D, Friberg H, Kober L, Kjaergaard J. Targeted temperature management at 33 degrees C versus 36 degrees C and impact on systemic vascular resistance and myocardial function after out-of-hospital cardiac arrest: a sub-study of the Target Temperature Management Trial. Circ Cardiovasc Interv. 2014 Oct;7(5):663-72. doi: 10.1161/CIRCINTERVENTIONS.114.001556. Epub 2014 Sep 30.
PMID: 25270900DERIVEDWesthall E, Rosen I, Rossetti AO, van Rootselaar AF, Kjaer TW, Horn J, Ullen S, Friberg H, Nielsen N, Cronberg T. Electroencephalography (EEG) for neurological prognostication after cardiac arrest and targeted temperature management; rationale and study design. BMC Neurol. 2014 Aug 16;14:159. doi: 10.1186/s12883-014-0159-2.
PMID: 25267568DERIVEDBeurskens CJ, Horn J, de Boer AM, Schultz MJ, van Leeuwen EM, Vroom MB, Juffermans NP. Cardiac arrest patients have an impaired immune response, which is not influenced by induced hypothermia. Crit Care. 2014 Jul 30;18(4):R162. doi: 10.1186/cc14002.
PMID: 25078879DERIVEDNielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wise MP, Aneman A, Al-Subaie N, Boesgaard S, Bro-Jeppesen J, Brunetti I, Bugge JF, Hingston CD, Juffermans NP, Koopmans M, Kober L, Langorgen J, Lilja G, Moller JE, Rundgren M, Rylander C, Smid O, Werer C, Winkel P, Friberg H; TTM Trial Investigators. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013 Dec 5;369(23):2197-206. doi: 10.1056/NEJMoa1310519. Epub 2013 Nov 17.
PMID: 24237006DERIVEDFerreira Da Silva IR, Frontera JA. Targeted temperature management in survivors of cardiac arrest. Cardiol Clin. 2013 Nov;31(4):637-55, ix. doi: 10.1016/j.ccl.2013.07.010.
PMID: 24188226DERIVEDNielsen N, Winkel P, Cronberg T, Erlinge D, Friberg H, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wise MP, Aneman A, Wetterslev J. Detailed statistical analysis plan for the target temperature management after out-of-hospital cardiac arrest trial. Trials. 2013 Sep 17;14:300. doi: 10.1186/1745-6215-14-300.
PMID: 24044764DERIVEDCronberg T, Nielsen N. Fever after therapeutic hypothermia - does rebound pyrexia matter? Resuscitation. 2013 Aug;84(8):1011-2. doi: 10.1016/j.resuscitation.2013.05.006. Epub 2013 May 17. No abstract available.
PMID: 23688929DERIVEDNielsen N, Friberg H. Can we conclude anything yet about the effect of hypothermia for patients arresting in-hospital? Resuscitation. 2013 May;84(5):535-6. doi: 10.1016/j.resuscitation.2013.02.009. Epub 2013 Mar 13. No abstract available.
PMID: 23499577DERIVEDNielsen N, Wetterslev J, al-Subaie N, Andersson B, Bro-Jeppesen J, Bishop G, Brunetti I, Cranshaw J, Cronberg T, Edqvist K, Erlinge D, Gasche Y, Glover G, Hassager C, Horn J, Hovdenes J, Johnsson J, Kjaergaard J, Kuiper M, Langorgen J, Macken L, Martinell L, Martner P, Pellis T, Pelosi P, Petersen P, Persson S, Rundgren M, Saxena M, Svensson R, Stammet P, Thoren A, Unden J, Walden A, Wallskog J, Wanscher M, Wise MP, Wyon N, Aneman A, Friberg H. Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design. Am Heart J. 2012 Apr;163(4):541-8. doi: 10.1016/j.ahj.2012.01.013.
PMID: 22520518DERIVEDNielsen N, Friberg H. Insights from the evidence evaluation process--do we have the answers for therapeutic hypothermia? Resuscitation. 2011 May;82(5):501-2. doi: 10.1016/j.resuscitation.2011.02.041. Epub 2011 Mar 10. No abstract available.
PMID: 21458906DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Niklas Nielsen, MD, PhD
Helsingborgs lasarett, Region Skåne, Sweden
- PRINCIPAL INVESTIGATOR
Janneke Horn, MD, PhD
Academisch Medisch Centrum, Amsterdam, the Netherlands
- PRINCIPAL INVESTIGATOR
Hans Friberg, MD, PhD
Lund University Hospital, Lund, Sweden
- PRINCIPAL INVESTIGATOR
Tobias Cronberg, MD, PhD
Lund University Hospital, Lund, Sweden
- PRINCIPAL INVESTIGATOR
Michael Wanscher, MD, PhD
Copenhagen University Hospital, Copenhagen, Denmark
- PRINCIPAL INVESTIGATOR
Christian Hassager, MD, DMSc
Copenhagen University Hospital, Copenhagen, Denmark
- PRINCIPAL INVESTIGATOR
Jesper Kjaergaard, MD, PhD
Copenhagen University Hospital, Copenhagen, Denmark
- PRINCIPAL INVESTIGATOR
Jan Hovdenes, MD, PhD
Oslo University Hospital, Oslo, Norway
- PRINCIPAL INVESTIGATOR
Pascal Stammet, MD
Centre Hospitalier du Luxembourg
- PRINCIPAL INVESTIGATOR
Yvan Gasche, MD, PhD
Geneva University Hospital, Geneva, Switzerland
- PRINCIPAL INVESTIGATOR
Thomas Pellis, MD, PhD
Santa Maria degli Angeli Hospital, Pordenone, Italy
- PRINCIPAL INVESTIGATOR
Matt Wise, MD, DPhil
University Hospital of Wales, Cardiff, UK
- PRINCIPAL INVESTIGATOR
Anders Åneman, MD, PhD
Liverpool Hospital, Sydney, Australia
- PRINCIPAL INVESTIGATOR
Jørn Wetterslev, MD, PhD
Copenhagen Trial Unit, Copenhagen University Hospital, Copenhagen, Denmark
- PRINCIPAL INVESTIGATOR
Michael Kuiper, MD, PhD
Leeuwarden Hospital, Leeuwarden, the Netherlands
- PRINCIPAL INVESTIGATOR
David Erlinge, MD, PhD
Lund University Hospital, Lund, Sweden
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Consultant in Anesthesia and Intensive Care, MD, PhD
Study Record Dates
First Submitted
November 25, 2009
First Posted
November 26, 2009
Study Start
November 1, 2010
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
July 10, 2013
Record last verified: 2013-07